pharmacopeia

Dry Skin

71 drugs95,484 FAERS reportsMedDRA PT
GET
/api/v1/reaction/dry-skin
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D007057

Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.

Source: U.S. National Library of Medicine — MeSH (Ichthyosis)

Drugs reporting Dry Skin (71)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Chlorogenic Acid1100%
  2. 2Racepinephrine1434%
  3. 3Dichromate Ion233%
  4. 4Adapalene45,63425%
  5. 5Salicylic Acid12,76524%
  6. 6Palovarotene1019%
  7. 7Sulfur2,59117%
  8. 8Asiatic Acid213%
  9. 9Octocrylene30713%
  10. 10Avobenzone30713%
  11. 11Octisalate23612%
  12. 12Pyrithione559.8%
  13. 13Trifarotene158.7%
  14. 14Aconite28.3%
  15. 15Aluminum Acetate37.5%
  16. 16Mafenide26.5%
  17. 17Aluminum Sulfate46.1%
  18. 18Aluminum Sulfate Tetradecahydrate46.1%
  19. 19Hydroquinone665.9%
  20. 20Futibatinib115.9%
  21. 21Depemokimab15.6%
  22. 22Pimecrolimus875.4%
  23. 23Dupilumab23,3165.3%
  24. 24Hypromellose 220825.3%
  25. 25Isotretinoin2,3784.9%
  26. 26Barium Iodate24.7%
  27. 27Ripretinib2174.3%
  28. 28Mechlorethamine974.3%
  29. 29Tralokinumab2394.3%
  30. 30Avutometinib224.2%
  31. 31Defactinib224.2%
  32. 32Permethrin714.1%
  33. 33Mirdametinib34.0%
  34. 34Talquetamab723.9%
  35. 35Brensocatib313.9%
  36. 36Halobetasol583.9%
  37. 37Flurandrenolide123.9%
  38. 38Panitumumab5683.8%
  39. 39Titanium Dioxide133.7%
  40. 40Alclometasone113.6%
  41. 41Tretinoin3103.6%
  42. 42Zafirlukast303.5%
  43. 43Tazarotene463.4%
  44. 44Lebrikizumab473.4%
  45. 45Delgocitinib63.4%
  46. 46Naftifine113.3%
  47. 47Clobetasol3643.3%
  48. 48Witch Hazel103.2%
  49. 49Pemigatinib253.2%
  50. 50Afatinib1993.0%
  51. 51Octinoxate113.0%
  52. 52Ponatinib1482.9%
  53. 53Glycopyrronium432.9%
  54. 54Fluocinolone1192.8%
  55. 55Cabozantinib1,2982.8%
  56. 56Crisaborole2562.7%
  57. 57Lapatinib3972.6%
  58. 58Selumetinib322.3%
  59. 59Vandetanib412.3%
  60. 60Fluocinonide1292.3%
  61. 61Nemolizumab2232.3%
  62. 62Sarecycline42.2%
  63. 63Gefitinib1932.2%
  64. 64Erdafitinib252.1%
  65. 65Tapinarof352.1%
  66. 66Lazertinib122.1%
  67. 67Selenium Sulfide182.0%
  68. 68Abrocitinib551.5%
  69. 69Osimertinib3711.2%
  70. 70Clascoterone151.1%
  71. 71Benzoyl Peroxide1,758—

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Ichthyosis as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients